Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over

Table 3 Perioperative characteristics and post-liver transplantation complications n (%)

	Donors < 70 years old (n = 212)	Donors ≥ 70 years old (n = 212)	P value
CIT (min)	386 ± 168 (100-1038)	445 ± 158 (60-975)	0.00
WIT (min)	64 ± 17 (40-200)	61 ± 13 (30-130)	0.04
Transfusional requeriments
RBC (U)	6 (3-10)	5 (3-10)	0.98
FFP (U)	12 ± 9 (0-60)	13 ± 9 (0-58)	0.40
Platelets (U)	3 ± 3 (0-37)	3 ± 3 (0-16)	0.53
Basal immunosuppressant drugs
Cyclosporine plus steroids	33 (15.6)	30 (14.3)	0.71
Tacrolimus plus steroids	179 (84.4)	180 (85.7)
ICU stay (d)	4 (2-5)	4 (2-6)	0.58
Hospital stay (d)	18 ± 17 (0-105)	16 ± 12 (0-83)	0.34
Primary non-function	6 (2.8)	7 (3.3)	0.24
Acute rejection	61 (28.8)	53 (25.1)	0.39
Infectious complications	56 (26.4)	41 (19.3)	0.08
Medical complications	90 (42.5)	93 (43.9)	0.76
Surgical complications	38 (17.9)	34 (16)	0.60
Vascular complications	11 (5.2)	14 (6.6)	0.80
Biliary complications	24 (11.3)	11 (5.2)	0.41
Reoperation	27 (12.7)	20 (9.4)	0.28
De novo tumors	24 (11.3)	22 (10.4)	0.57
HCV recurrence	73 (61.9)	42 (57.5)	0.55
Days	141 (58-535)	148 (51-316)	0.90
Hepatitis F3 or F4	18 (24.7)	21 (50)	0.00
Fibrosing cholestatic hepatitis	7 (9.6)	7 (16.7)	0.26
Re-transplantation	11 (5.2)	12 (5.7)	0.83

CIT: Cold ischemia time; WIT: Warm ischemia time; RBC: Red blood cells; FFP: Fresh frozen plasma; ICU: Intensive care unit.